Notice of Registration - 2012
[Federal Register Volume 77, Number 202 (Thursday, October 18, 2012)]
[Notices]
[Page 64144]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-25635]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration;
Lin Zhi International, Inc.
By Notice dated May 15, 2012, and published in the Federal Register
on May 22, 2012, 77 FR 30326, Lin Zhi International, Inc., 670 Almanor
Avenue, Sunnyvale, California 94085, made application by renewal to the
Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances:
| Drug |
Schedule |
| Tetrahydrocannabinols (7370) |
I |
| 3,4-Methylenedioxymethamphetamine (MDMA) (7405) |
I |
| Cocaine (9041) |
II |
| Oxycodone (9143) |
II |
| Hydrocodone (9193) |
II |
| Methadone (9250) |
II |
| Dextropropoxyphene, bulk (non-dosage forms) (9273) |
II |
| Morphine (9300) |
II |
The company plans to manufacture the listed controlled substances
as bulk reagents for use in drug abuse testing.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Lin Zhi International, Inc., to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Lin Zhi International Inc., to ensure that
the company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history.
Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR
1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: October 9, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-25635 Filed 10-17-12; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |